The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Given the prevalence of low‐pathogenic but highly infectious Omicron variants, a cohort study was conducted to assess the response and duration of novel coronavirus‐inactivated vaccine‐induced antibodies 1 year after the third dose (Day 641). Blood samples were collected and anti‐spike neutralizing antibodies (neutralizing antibody), total antibodies against the receptor‐binding domain of the spike...